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Abstract
Introduction. The aim of the study was to evaluate cardiovascular risk factors in patients after retinal artery occlusion 
(RAO). Additionally, our findings were compared with the results of epidemiological studies on the prevalence of cardio-
vascular risk factors in the Polish population.
Material and methods. We conducted a retrospective study which involved a group of 100 patients admitted to the 
ophthalmology service due to RAO in 2004–2014.
Results. In our study group, hypertension was found in 78% of patients, hypercholesterolemia in 67% of patients, ische-
mic heart disease in 53% of patients, previous myocardial infarction in 20% of patients, heart failure in 17% of patients, 
diabetes type 2 in 16% of patients, atrial fibrillation in 14% of patients, and kidney dysfunction in 11% of patients. 
Twelve percent of patients had a history of stroke, and 31% were smokers. Doppler ultrasonography (USG) showed 
carotid atherosclerotic plaques in 78% of patients and ≥ 70% carotid artery stenosis in 33% of patients. Transthoracic 
echocardiography revealed aortic valve calcifications in 63% of patients.
Conclusions. Cardiovascular risk factors are present in a large majority of patients with RAO. Compared to the general 
population, patients with RAO often suffer from hypertension, hypercholesterolemia, type 2 diabetes and renal dysfun-
ction. Due to an association between RAO and cardiovascular risk factors, appropriate diagnostic work-up is of major 
importance in these patients. Basic investigations in patients after a RAO event should include carotid artery Doppler 
ultrasound, echocardiography, electrocardiography, blood pressure measurement, and laboratory tests
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Introduction
Retinal artery occlusion (RAO) is an ophthalmologic emer-
gency that requires urgent diagnosis and treatment. The 
major cause of RAO is carotid artery and aortic arch ath-
erosclerosis, and less frequent causes include mitral and 
aortic valve disease, infective endocarditis, coagulopathies, 
atrial fibrillation, and autoimmune diseases including 
giant cell arteritis. Population studies indicate that RAO is 
associated with increased acute coronary syndrome (ACS) 
and stroke rates [1, 2]. Incident RAO in patients with atrial 
fibrillation is associated with an increased thromboembolic 
risk [3]. The aim of this study was to evaluate cardiovascular 
risk factors in patients with a RAO event and compare these 
findings with epidemiological data on the prevalence of 
cardiovascular risk factors in the Polish population.
Material and methods
The study included patients admitted to the ophthalmology 
service due to RAO over 11 years (in 2004–2014). The 
study was a retrospective analysis which was approved by 
the Bioethics Committee at the regional Świętokrzyskie 
branch of the Polish Chamber of Physicians and Dentists. 
The inclusion criterion was the finding of RAO on physical 
examination. The exclusion criterion was the diagnosis or 
suspicion of giant cell arteritis.
Patients with the diagnosis of RAO (60% men) were 
divided into 2 groups: those below 65 years of age (21%) 
and those 65 years of age and above (79%). The evaluation 
included concomitant conditions, cardiovascular risk fac-
tors, carotid ultrasound, echocardiography, electrocardio-
graphy, and laboratory tests. The history regarding tobacco 
smoking was obtained from 71% of study participants. 
The following parameters were included in the statistical 
analysis: gender, presence of cardiovascular disease (CVD), 
diabetes type 2, tobacco smoking, carotid artery lesions, 
echocardiographic parameters, total cholesterol, high-den-
sity lipoprotein (HDL) cholesterol, low-density lipoprotein 
(LDL) cholesterol, triglycerides (TG), creatinine, estimated 
glomerular filtration rate (eGFR) (using the Modification of 
Diet in Renal Disease [MDRD] formula), and fasting blood 
glucose. LDL cholesterol level was estimated using the 
Friedewald formula. Echocardiography was performed in 
89% of patients and included evaluation of left atrial an-
teroposterior (LA-AP) dimension in the long axis parasternal 
view, left ventricular ejection fraction (LVEF), aortic valve 
calcifications, and the presence of aortic stenosis (AS), 
defined as the mean aortic valve pressure gradient above 
10 mm Hg.
Hypercholesterolemia was defined according to the 
current European Society of Cardiology guidelines on CVD 
prevention as total cholesterol level ≥ 190 mg/dL or LDL 
cholesterol level ≥ 115 mg/dL [4]. This group also includ-
ed patients who were treated with statins due to elevated 
cholesterol levels or for secondary CVD prevention at the 
time of the diagnosis of RAO.
Hypertension was defined as systolic blood pressure 
> 140 mm Hg and/or diastolic blood pressure > 90 mm Hg 
or antihypertensive drug treatment on admission. Renal 
dysfunction was defined as eGFR below 60 mL/min.
Carotid Doppler ultrasonography was performed in 80% 
of patients. Ultrasound studies were performed according 
to the Polish Ultrasound Society recommendations [5]. 
Significant lesions were defined as vessel lumen stenosis 
of ≥ 70%. The intima-media thickness was measured ap-
prox. 10 mm proximal to the carotid bifurcation and values 
> 0.9 mm were considered abnormal. Atherosclerotic plaque 
was defined as the intima-media thickness > 1.5 mm or 
a focal thickening to > 50% of the vessel wall thickness.
Statistical analysis was performed using the Statistica 
software. Population characteristics were reported as mean 
values ± standard deviation or numbers and percentages. 
Parametric data were evaluated using the Student t test, 
and differences in patient group sizes within the study 
population were evaluated using the chi-square test. 
P < 0.05 was considered statistically significant.
Results
In 2004–2014, overall 19,117 patients were admitted to 
the ophthalmology department. The diagnosis of RAO was 
made in 100 patients (60% males), amounting to 0.52% of 
all hospitalization. The patient age ranged from 43 to 93 
years, mean 71.8 years (± 10.4). Diagnoses in the evalua-
ted population of patients with RAO included hypertension 
(78%), hypercholesterolemia (67%), ischemic heart disease 
(53%), previous myocardial infarction (20%), diabetes 
type 2 (16%), previous stroke (12%), atrial fibrillation (14%), 
heart failure (17%), chronic kidney disease (11%), and 
tobacco smoking (31%) (Table 1). Imaging studies showed 
carotid artery atherosclerotic plaques in 78% of patients, 
≥ 70% carotid artery stenosis (CAS) in 33% of patients, 
aortic valve calcifications in 63% of patients, and at least 
mild aortic stenosis in 15.7% of patients. The mean inter-
ventricular septum thickness was 11.4 mm, mean LA-AP 
dimension was 39.9 mm, and mean LVEF was 55.3%. The 
mean values of laboratory parameters in patients with RAO 
included total cholesterol of 205 mg/dL, LDL cholesterol 
126 mg/dL, HDL cholesterol 47.6 mg/dL, TG 147.9 mg/dL, 
creatinine 1.1 mg/dL, eGFR (MDRD) 69.5 mL/min, and 
fasting blood glucose level of 102 mg/dL (Table 2).
The study population was divided into patients 
< 65 and ≥ 65 years of age. The older patients were 
found to have significantly higher rates of hypertension 
(57 vs. 83%, p = 0.009), ischemic heart disease (33 vs. 
58%, p = 0.04), atrial fibrillation (0 vs. 17.7%, p = 0.037), 
and heart failure (0 vs. 21.5%, p = 0.019). Patients below 
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Table 1. Cardiovascular risk factors in patients with retinal artery occlusion in the overall study group and in patients < 65 and ≥ 65 years 
of age
Parameter Overall 
(N = 100)
< 65 years 
(N = 21)
≥ 65 years 
(N = 79)
p*
Number of patients 100 21 79
Age, years (SD) 71.8 (10.4) 56.4 (6.2) 75.9 (6.2)
Males, n [%] 60 (60) 15 (71) 45 (56) 0.2
Hypertension, n [%] 78 (78) 12 (57) 66 (83) 0.009
Hypercholesterolemia, n [%] 67 (67) 13 (61.9) 54 (68.3) 0.57
Cardiovascular disease, n [%] 53 (53) 7 (33) 46 (58) 0.04
History of myocardial infarction, n [%] 20 (20) 2 (9) 18 (22.7) 0.17
Diabetes type 2, n [%] 16 (16) 1 (4.7) 15 (19) 0.11
Previous stroke, n [%] 12 (12) 2 (9) 10 (12.6) 0.69
Atrial fibrillation, n [%] 14 (14) 0 (0) 14 (17.7) 0.037
Heart failure, n [%] 17 (17) 0 (0) 17 (21.5) 0.019
Kidney dysfunction, n [%] 11 (11) 0 (0) 11 (13.9) 0.06
Tobacco smoking, n [%] 22(31) 10 (62) 12 (22) 0.001
*For comparison of patients < 65 and ≥ 65 years of age
Table 2. Laboratory parameters in patients with retinal artery occlusion in the overall study group and in patients < 65 and ≥ 65 years  
of age
Parameter Overall 
(N = 100)
< 65 years 
(N = 21)
≥ 65 years 
(N = 79)
p*
Carotid atherosclerotic plaques, n [%] 63 (78) 12 (63) 51 (85) 0.03
Carotid artery stenosis, n [%] 27 (33) 5 (26) 22 (36) 0.6
Interventricular septal thickness [mm] 11.4 ± 2.5 10.5 ± 1.4 11.4 ± 1.6 0.47
LA-AP dimension [mm] 39.9 ± 7.3 35 ± 16.2 41.3 ± 6.9 0.0003
LVEF [%] 55.3 ± 7.8 59.1 ± 11.5 54.1 ± 2.5 0.0075
Aortic valve calcifications, n [%] 56 (63) 7 (33) 49 (62) 0.018
Aortic stenosis, n [%] 14 (15.7) 1 (4.7) 13 (16.4) 0.169
Total cholesterol [mg/dL] 205.3 ± 67.2 227 ± 38.4 199 ± 31 0.07
LDL cholesterol [mg/dL] 126.2 ± 51.6 145 ± 35.8 120.6 ± 26.7 0.048
HDL cholesterol [mg/dL] 47.6 ± 12.3 54 ± 11.7 45.7 ± 17.9 0.01
TG [mg/dL] 147.9 ± 71.8 157 ± 71.8 145 ± 63.1 0.27
Creatinine [mg/dL] 1.1 ± 0.4 0.97 ± 0.2 1.14 ± 0.4 0.11
eGFR by MDRD [mL/min] 69.5 ± 25 82.2 ± 16 66.1 ± 18.5 0.008
Fasting blood glucose [mg/dL] 102 ± 17.6 100.9 ± 11.3 102 ± 11.3 0.41
*For comparison of patients < 65 and ≥ 65 years of age
65 years of age were more frequently smokers (62 vs. 
22%, p = 0.001). No differences were found in regard 
to the rates of hypercholesterolemia (61.9 vs. 68.3%, 
p = 0.57), previous myocardial infarction (9 vs. 22.7%, 
p = 0.17), diabetes type 2 (4.7 vs. 19%, p = 0.11), previous 
stroke (9 vs. 12.6%, p = 0.69), and kidney dysfunction 
(0 vs. 13.9%, p = 0.06).
Imaging studies showed higher rates of carotid ath-
erosclerotic plaques (63 vs. 85%, p = 0.03), aortic valve 
calcifications (33 vs. 62%, p = 0.018), and higher LA-AP 
dimension (35 vs. 41 mm, p = 0.0003) in older patients, 
while LVEF was significantly higher in younger patients 
(59 vs. 54%, p = 0.0075). No differences were found in 
the rates of CAS (26 vs. 36%, p = 0.6), at least mild aortic 
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stenosis (4.7 vs. 16.4%, p = 0.169), and interventricular 
septal thickness (11.4 vs. 10.5 mm, p = 0.47).
Laboratory tests showed significantly higher mean LDL 
cholesterol level (145 vs. 120 mg/dL, p = 0.048), HDL cho-
lesterol (54 vs. 45 mg/dL, p = 0.01), and eGFR by MDRD 
(82.2 vs. 66.1 mL/min, p = 0.008) in younger patients. 
No differences were found in the mean total cholesterol 
(227 vs. 199 mg/dL, p = 0.07), TG (157 vs. 145 mg/dL, 
p = 0.27), creatinine (0.97 vs. 1.14 mg/dL, p = 0.11), and 
fasting blood glucose (100 vs. 102 mg/dL, p = 0.41).
Discussion
The association of cardiovascular risk factors and CVD with 
RAO has been well documented [6–9]. Risk factors for RAO 
include hypercholesterolemia, hypertension, carotid artery 
and aortic arch atherosclerosis, ischemic heart disease, 
kidney dysfunction, diabetes, stroke, smoking, mitral and 
aortic valve disease, and thrombi or vegetations which 
might be a source of embolic material [8, 10]. Multiple 
studies show that RAO is a predictor of ACS, stroke, and 
mortality [1, 2, 7]. Chang et al. showed a 70% increase in 
the risk of ACS in patients with RAO, and even higher in 
patients with central retinal artery occlusion (CRAO) [1]. In 
2012, the same authors reported that RAO increased the 
risk of stroke by a factor of 2.07, and the risk was increased 
more than threefold in patients below 60 years of age [2]. 
Based on an analysis of 8580 patients including 111 with 
the diagnosis of RAO, Wang et al. showed an increased risk 
of all-cause mortality (HR 1.3) and mortality due to stroke 
(HR 2.0) in patients after a RAO event [7].
Considering the current European Society of Cardio-
logy (ESC) guidelines on the management of peripheral 
arterial disease, RAO in a patient with CAS should be con-
sidered symptomatic carotid artery disease equivalent to 
a transient ischemic attack (TIA) or stroke, with significant 
implications in regard to the management of patients 
with CAS. In patients with 70–99% CAS and RAO, carotid 
endarterectomy (CEA) should be performed, optimally 
within 2 weeks after RAO. In patients with 50–69% CAS, 
indications for CEA are not so clear. All patients with a RAO 
event should be offered lifelong treatment with antiplatelet 
drugs and a statin [11].
Our findings were compared with the epidemiological 
NATPOL 2011 study that evaluated cardiovascular risk 
factor rates in the Polish population [12]. The prevalence 
of hypertension in our patients with RAO was much higher 
compared to the general Polish population evaluated in the 
NATPOL 2011 study (78 vs. 31.9%) [13]. Regarding lipid 
parameters, our patients with RAO had more hypercholes-
terolemia (67% vs. 61.1%) and higher total cholesterol, 
LDL cholesterol, and TG levels compared to the NATPOL 
2011 study population (205 vs. 198 mg/dL, 126 vs. 
123 mg/dL, and 147 vs. 122 mg/dL, respectively) while 
the mean HDL cholesterol in patients with RAO was lower 
(47 vs. 50 mg/dL) [14]. In a similar WOBASZ II study in the 
Polish population, the rate of hypercholesterolemia was 
67%, close to our findings [15].
Patients with RAO in our study had more diabetes 
compared to the NATPOL 2011 study population (16 vs. 
6.7%) [16].
In our study population, kidney dysfunction was also 
more common (11 vs. 5.8%) but in contrast to the NAT-
POL 2011 study, albuminuria was not measured in our 
study. We believe that evaluation for albuminuria in patients 
with RAO would increase the proportion of patients with the 
diagnosis of chronic kidney disease [13].
The proportion of smokers was 27% in the NATPOL 
2011 study population compared to 31% in our patients 
with RAO [13].
Table 3 summarized studies that evaluated the rates 
of cardiovascular disease and risk factors in patients with 
RAO. Studies that evaluated only patients with CRAO or 
branch retinal artery occlusion (BRAO) were excluded from 
the analysis. One of the most important observations was 
made in regard to carotid artery disease. Study findings 
indicate that ≥ 70% CAS is present in 21–33% of patients 
with RAO. In these studies, the most common cardiovascu-
lar condition in patients with RAO was hypertension, except 
for the study by Hayreh et al. in which the most common 
cardiovascular conditions were carotid atherosclerotic 
plaques followed by hypercholesterolemia and hyperten-
sion [8]. The prevalence of carotid atherosclerotic plaques 
in our patients with RAO was 69–78%, and similar rates 
were reported by Hayreh et al. [8]. The proportion of smok-
ers among patients with RAO was reported at 31–40%. 
Thus, the most common modifiable cardiovascular risk 
Table 3. Comparison of studies evaluating cardiovascular disease 
and risk factors in patients with retinal artery occlusion
Parameter Hayreh 
et al. [8]
Hankey 
et al. [17]
Schmidt 
et al. [18]
Number of patients [n] 375 98 416
Mean age [years] 62,5 64 66
Males [%] 59 55 65.9
Hypertension [%] 52 56 75.9
Hypercholesterolemia [%] 60 53 34.7
Ischemic heart disease [%] 25 18 23.8
Diabetes type 2 [%] 17 5 18.2
Smoking [%] 33 40 32.7
Previous stroke [%] 18 – 14.2
Carotid artery stenosis 
≥ 70% [%]
– 24 21
Carotid atherosclerotic 
plaques [%]
69 – 31
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factors in patients with RAO are hypertension, hypercho-
lesterolemia, and smoking [8, 17–18]. In our study group, 
the most common risk factors for RAO were hypertension, 
hypercholesterolemia, and ischemic heart disease.
A history of stroke is reported in 14–18% of patients 
with RAO [8, 18], compared to 12% in our patients.
Of note, only two patients in our study group, both 
below 65 years of age, had no established cardiovascular 
risk factors.
Rudkin et al. and Calizzo et al. focused on newly diag-
nosed conditions in patients with CRAO. In their group of 
patients with CRAO, Rudkin et al. found hypercholestero-
lemia in 73% of patients, and this diagnosis was made only 
after the occurrence of CRAO in 36% of patients. Carotid 
artery stenosis of more than 50% was diagnosed in 9 (27%) 
patients, 6 of which were treated with endarterectomy or 
carotid artery stenting [19]. Calizzo et al. showed that CAS 
and hypercholesterolemia were the most common undia-
gnosed conditions in patients with CRAO. On admission, 
CAS was diagnosed in 3% of patients compared to 38% 
at discharge, and hypercholesterolemia was diagnosed 
in 8% of patients on admission and in 44% of patients at 
discharge [20].
Conclusions
Cardiovascular risk factors are present in a large majority 
of patients with RAO. Compared to the general population, 
patients with RAO have more hypertension, hypercholester-
olemia, type 2 diabetes and renal dysfunction. They are also 
characterised by higher total cholesterol, LDL cholesterol, 
and TG levels, and lower HDL cholesterol levels.
The most common risk factors for RAO in the study 
population were hypertension, hypercholesterolemia, male 
gender, and ischemic heart disease. The most common 
cardiovascular risk factors in patients < 65 years of age 
were male gender, hypercholesterolemia, hypertension, 
and smoking, while hypertension, hypercholesterolemia, 
ischemic heart disease, and male gender were the most 
common risk factors in older patients.
When age-related differences were analysed, patients 
< 65 years of age with RAO were found to have less structural 
heart disease but significantly higher LDL and HDL choles-
terol levels and were significantly more frequently smokers.
Investigations in patients with RAO should include carot-
id artery Doppler ultrasound, blood pressure measurement, 
lipid levels, echocardiography, and electrocardiography.
Streszczenie
Wstęp. Celem pracy była ocena obecności czynników ryzyka sercowo-naczyniowego w grupie pacjentów po epizodzie 
zamknięcia naczynia tętniczego siatkówki (RAO). Cel dodatkowy stanowiło porównanie wyników badań epidemiolo-
gicznych dotyczących rozpowszechnienia czynników ryzyka sercowo-naczyniowego wśród ludności Polski z wynikami 
przeprowadzonego badania.
Materiał i metody. Przeprowadzono badanie retrospektywne, które objęło grupę 100 pacjentów hospitalizowanych na 
oddziale okulistyki w latach 2004–2014 z powodu RAO.
Wyniki. W badanej grupie nadciśnienie tętnicze stwierdzono u 78% pacjentów, hipercholesterolemię u 67% pacjentów, 
chorobę niedokrwienną serca u 53% pacjentów, zawał serca u 20% pacjentów, niewydolność krążenia u 17% pacjen-
tów, cukrzycę typu 2 u 16% pacjentów, migotanie przedsionków u 14% pacjentów, upośledzoną funkcję nerek u 11% 
pacjentów. Dwanaście procent pacjentów było po udarze mózgu. Nikotynizm stwierdzono u 31% pacjentów. Blaszkę 
miażdżycową w wykonanych badaniach ultrasonografii (USG) metodą Dopplera uwidoczniono u 78% pacjentów, zwęże-
nie tętnicy szyjnej równe lub większe 70% dotyczyło 33% pacjentów. W wykonanych badaniach echokardiograficznych 
stwierdzono obecność zwapnień na płatkach zastawki aortalnej u 63% pacjentów.
Wnioski. Znamienna większość pacjentów z rozpoznanym RAO jest obciążona czynnikami ryzyka sercowo-naczyniowego. 
Pacjenci ci, w porównaniu z populacją ogólną, częściej chorują na nadciśnienie tętnicze, hipercholesterolemię, cukrzy-
cę typu 2, częściej też stwierdza się u nich dysfunkcję nerek. Ze względu na związek między RAO a czynnikami ryzyka 
sercowo-naczyniowego niezwykle istotna jest odpowiednia diagnostyka. Wśród podstawowych badań u pacjentów po 
epizodzie RAO powinny się znaleźć badanie USG tętnic szyjnych z oceną doplerowską, badanie echokardiograficzne 
i elektrokardiograficzne, pomiar ciśnienia tętniczego a także badania laboratoryjne.
Słowa kluczowe: czynniki ryzyka sercowo-naczyniowego, zator tętnicy siatkówki, hipercholesterolemia, nadciśnienie 
tętnicze, udar mózgu
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